N CURE PHARMACEUTICALS PRIVATE LIMITED
N CURE PHARMACEUTICALS PRIVATE LIMITED is a UTTAR PRADESH based PRIVATE LIMITED company, Registered at dated 10-AUG-2023 on Ministry of Corporate Affairs(MCA), The Corporate Identification Number (CIN) of N CURE PHARMACEUTICALS PRIVATE LIMITED is U47721UP2023PTC187143 and registration number is 187143.
It has been classified as COMPANY LIMITED BY SHARES and is registered under Registar of Companies ROC KANPUR India. Authorized share capital of N CURE PHARMACEUTICALS PRIVATE LIMITED is Rs. 1000000 and its paid up capital is Rs. 100000. It aspire to serve in TRADING activities across the India.
Its Annual General Meeting (AGM) was lastly conducted on and as per the records of Ministry of Corporate Affairs (MCA), its balance sheet was last filed on .
N CURE PHARMACEUTICALS PRIVATE LIMITED has 2 directors MAMTA NIRWAL, VARUN DESHWAL,
The registered Email address of N CURE PHARMACEUTICALS PRIVATE LIMITED is Dr.Gaurav.nirwal@gmail.com and its registered address is DUKAN NO.5 CIRCULAR ROAD MUZAFFAR NAGAR CITY MUZAFFARNAGAR MUZAFFARNAGAR UP 251002 IN UTTAR PRADESH UTTAR PRADESH india 251002.
The current status of N CURE PHARMACEUTICALS PRIVATE LIMITED shows as ACTIVE
COMPANY BASIC DETAILS
N CURE PHARMACEUTICALS PRIVATE LIMITED
ROC KANPUR
ACTIVE
TRADING
U47721UP2023PTC187143
10-AUG-2023
COMPANY LIMITED BY SHARES
NON-GOVT COMPANY
PRIVATE
1000000
100000
CONTACT DETAILS
251002
INDIA
DUKAN NO.5 CIRCULAR ROAD MUZAFFAR NAGAR CITY MUZAFFARNAGAR MUZAFFARNAGAR UP 251002 IN
Dr.Gaurav.nirwal@gmail.com
DIRECTOR DETAILS
DIN | Director Name | Designation | Appointment Date |
---|---|---|---|
08991703 | MAMTA NIRWAL | Director | 10/08/2023 |
08991704 | VARUN DESHWAL | Director | 10/08/2023 |
Details Updated by Companies
Quick Links
- All Registered company of UTTAR PRADESH
- Company Registered in UTTAR PRADESH
- All Registered company of MUZAFFARNAGAR in UTTAR PRADESH
- Listed Company
- Company Category
- Latest Registered Company
Contact Us for Update Extra Information about your company and services.